Company: PRTA
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001559053-25-000023
Chunk: 23

Company: PROTHENA CORP PUBLIC LTD CO
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 23
---
              5.15      $                   1,189  

The total intrinsic value of options exercised was nil 0.4

The following table summarizes the activity and related information for RSUs during the three months ended March 31, 2025:

                                                       Number of Units                   Weighted Average                     Weighted      Aggregate                  
                                                                                         Grant-Date                            Average      Intrinsic                  
                                                                                         Fair Value                          Remaining      Value                      
                                                                                                                           Contractual      (in thousands)             
                                                                                                                          Term (years)                                 
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Unvested at December 31, 2024                                               6,000      $                     51.80              0.71      $                      83  
  Units Granted                                                             284,874      14.95                                                                         
  Units Vested                                         —                                 —                                                                             
  Units Forfeited                                      ( 365)                            14.95                                                                         
  Unvested at March 31, 2025                                                290,509      $                     15.71              1.95      $                   3,595  
  Unvested and expected to vest at March 31, 2025                           252,608      $                     15.80              1.90      $                   3,126  

The fair value of RSUs was determined on the date of grant based on the market price of the Company’s ordinary shares as of that date. The fair value of the RSUs is recognized as an expense on a straight-line basis over the vesting period of each RSU. Upon the vesting of the RSUs, a portion of the shares vested are sold by the employee to satisfy employee withholding tax requirements (sell-to-cover). As of March 31, 2025, total compensation cost not yet recognized related to unvested RSUs was $ 4.2 2.94

10. Income Taxes

The major taxing jurisdictions for the Company are Ireland and the U. S. The Company recorded an income ta x benefit of$ 1.2 for the three months ended March 31, 2025, as compared to$ 2.2 respectively. The provision for income taxes differs from the statutory tax rate of 12.5 applicable to Ireland primarily due to Irish net operating losses for which a tax provision benefit is not recognized, U. S. income taxed at different rates, adjustments to deferred tax